Drug Shortages: Why They Happen, What Can Be Done About Them?
A Senate hearing on pharmaceutical shortages discusses America’s dependence on India and China, and what can be done to reshore.
Remembering Bill Parks
This tribute was originally published in Tax Notes on March 20, 2023. Bill Parks of Moscow, Idaho, was an American patriot in the best way
First-Ever House Select Committee on China Shows Washington’s Worry
House China Committee talks China. No war talk. But plenty of worry. What was said at the first ever hearing, one of Capitol Hill’s best hearings this year.
Senate Banking Committee Asks if Export Controls Against China are Working
A look inside the Feb 28 Senate hearing on China export controls, and the Banking Committee’s debate on how to best compete with the world’s No. 2 economy.
Senate Banking Committee Asks: Should China be Allowed to Buy U.S. Farmland?
Should China be allowed to buy U.S. farmland? What about agribusiness operations that are near military installments?
House Foreign Affairs Committee Spars Over China Export Controls
Another day, another hearing on China on Capitol Hill. The House Foreign Affairs Committee held a hearing on Feb. 28 titled “Combatting the Generational Challenge
U.S. Starts 2023 with $68.3 Billion Trade Gap; Goods Deficit Already at $91.08 Billion
The U.S. posted its usual trade deficit for the month of January. A look at what we buy, and who we buy it from.
Could ‘Reshoring’ Become a Political Fight Over the Next Two Years?
Former President Trump says the U.S. needs universal tariffs to fix trade imbalances with the world. And says China should no longer be on the Most Favored Nation trade list, giving it nearly duty-free access to the U.S. for thousands of products.
New Leadership Brings Change of Mood at House Ways & Means
Rep. Jason Smith puts globalist companies on notice for profit shifting. Says Chairmanship at House Ways & Means will focus on “shoring up” supply chains.
Why Medicine Costs So Much Money, Despite Imports from Low-Cost Nations
The Senate Commerce Committee takes the little known, and even less understood, Pharmacy Benefit Manager industry to task for high drug costs.
